Han Zhu, MD, Stanford University, Standford, CA, discusses risk factors for cardiotoxic events in patients treated with immune checkpoint inhibitors. Classical myocarditis that comes from viral syndromes usually has a young, predominantly male population. This has been observed in immune checkpoint inhibitor (ICI) myocarditis, whereby clinical and translational studies have demonstrated a predominantly female population. Additionally, patients with classical cardiac risk factors have less cardiac reserve to tolerate autoimmunity. This interview took place at the 37th Annual Meeting of the Society for Immunotherapy in Cancer (SITC 2022) in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
